JNJ holds investor meeting at NYSE to present strategy, pipeline, and long-term outlook

JOHNSON & JOHNSON

December 5, 2023: JNJ host Enterprise Business Review at NYSE for the investment community.
Presented overarching strategy, Innovative Medicine and MedTech pipelines, and long-term financial outlook.
Press release and webcast materials available at https://jnjbusinessreview.q4ir.com/.
No specific financial guidance, numbers, or changes disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.